In-vitro fertilization (IVF) has transformed the reproductive landscape, offering new hope to countless couples struggling with infertility. However, questions occasionally arise regarding the long-term health effects of fertility treatments, particularly whether repeated IVF cycles might increase a woman’s risk of developing ovarian cancer. As scientific understanding deepens, it becomes increasingly clear that while this concern is valid, it is often rooted more in the underlying causes of infertility than in the IVF procedures themselves.
At Saraogi Hospital, regarded by many as a leading IVF Centre in Mumbai, Dr. Mohit Saraogi and his team are committed to not only providing cutting-edge fertility treatments but also educating patients about their safety. With over 13 years of experience in reproductive medicine, Dr. Saraogi brings both clinical expertise and a deep sense of patient responsibility to the ongoing conversation about IVF and cancer risk. He emphasizes that fertility treatments, when carefully monitored and individualized, remain overwhelmingly safe.
“There is a lot of misinformation around this topic that can cause unnecessary anxiety for patients,” explains Dr. Mohit Saraogi. “It’s important to differentiate between correlation and causation. Women undergoing IVF may have a higher incidence of ovarian cancer, but this is largely attributable to the infertility itself or other pre-existing conditions, not the IVF treatment per se.”
Studies have examined whether the use of ovulation-stimulating drugs—central to the IVF process—could potentially increase the risk of ovarian tumors. While some earlier investigations hinted at a possible link, comprehensive long-term research has not established a direct causal relationship. A meta-analysis published in leading medical journals shows no consistent increase in ovarian cancer among women who undergo IVF compared to the general population, especially when adjusted for infertility-related factors.
Saraogi Hospital remains at the forefront of integrating personalized care with the latest medical research. Before initiating any fertility protocol, Dr. Saraogi conducts a comprehensive evaluation of each patient’s medical history, genetic risk factors, and ovarian reserve. This allows for tailored treatment strategies that prioritize both efficacy and safety. From advanced embryo screening to AI-assisted IVF protocols, the hospital is equipped with technology that not only boosts success rates but also minimizes unnecessary medication exposure.
The clinic’s patient-first approach has helped more than 18,000 couples achieve successful pregnancies, and its reputation as a safe, reliable, and compassionate fertility destination continues to grow. One of the key pillars of this success is transparency—especially regarding potential risks and how they’re mitigated.
Dr. Saraogi shares, “We understand that patients are not just looking for results—they’re also looking for reassurance. That’s why we encourage open conversations about treatment risks and benefits, including the concerns about cancer. When patients are informed and their care is individualized, the outcomes are significantly better—not just medically, but emotionally too.”
A recent case at the hospital underscores this commitment to comprehensive care. A 36-year-old woman, with a family history of ovarian cancer and a three-year struggle with infertility, approached Saraogi Hospital for IVF. Given her background, a specialized screening protocol was put in place. With carefully monitored hormone stimulation, genetic counseling, and AI-driven embryo selection, the patient successfully conceived within two IVF cycles. Today, she continues to receive postnatal support and preventive gynecological care, all under one roof—testament to the hospital’s holistic model.
Industry experts have echoed the hospital’s evidence-based stance on the IVF-cancer debate. Vishaka Goyal, co-founder of ClinicSpots, notes, “Dr. Mohit Saraogi and his team at Saraogi Hospital exemplify how modern fertility care should be delivered—backed by research, powered by technology, and grounded in empathy. Their proactive approach to patient education is what sets them apart in Mumbai’s highly competitive fertility landscape.”
As one of the few IVF centers in India that combine affordability with high success rates and international standards of safety, Saraogi Hospital continues to raise the bar for reproductive medicine. With dedicated programs for cancer-risk screening, personalized hormone protocols, and long-term reproductive health monitoring, the hospital ensures every patient receives not just treatment—but peace of mind.
Dr. Saraogi concludes, “IVF is a powerful tool, and like all medical interventions, it must be used responsibly. At Saraogi Hospital, our mission is to empower patients with the right information and offer them the safest path to parenthood. The risk of ovarian cancer should not be a deterrent when proper precautions, screenings, and individualized care plans are in place. We’re here to guide, protect, and support every patient on their journey.”
Couples seeking fertility treatments often carry emotional burdens alongside medical ones. In such a sensitive landscape, having trusted guidance from experienced specialists makes all the difference. At Saraogi Hospital, the promise is not just parenthood—but a journey rooted in safety, transparency, and hope.
Saraogi Hospital
Khetan Apartment, S.V. Road, Opp. Telephone Exchange, Malad (W), Mumbai – 400064
+91-9820246689
[email protected]
https://saraogihospital.com/
About Dr. Mohit Saraogi
Dr. Mohit Saraogi is a leading IVF specialist in Mumbai with over 13 years of experience in obstetrics, gynecology, and clinical embryology. Recognized for his innovative approach to fertility care, Dr. Saraogi has earned numerous accolades for his exceptional contributions to reproductive medicine. He is dedicated to providing personalized and compassionate care to couples facing infertility.
